Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BasimglurantNOE-101Phase 32 trials
Noema Pharma AG · Trigeminal Neuralgia, Tuberous Sclerosis Complex
- BAT1308Recombinant humanized anti-PD-1 monoclonal antibodyPhase 32 trials
Bio-Thera Solutions · Cervical Cancer, Advanced Solid Tumors
- BAT4406FPhase 32 trials
Bio-Thera Solutions · Optic Neuromyelitis Spectrum Disease, Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS)
- BAT5906Phase 32 trials
Bio-Thera Solutions · Diabetic Macular Edema (DME), Neovascular (Wet) Age-related Macular Degeneration
- bb2121BMS-986395Phase 32 trials
Bristol Myers Squibb · Multiple Myeloma
- BCD-217Phase 32 trials
Biocad · Melanoma Stage III, Melanoma (Skin), Melanoma
- BCD-248Phase 32 trials
Biocad · Relapsed/Refractory Multiple Myeloma, Myeloma Multiple
- BD MDIPhase 32 trials
AstraZeneca · Asthma
- BDB-001Phase 32 trials
Staidson (Beijing) Biopharmaceuticals Co., Ltd · ANCA Associated Vasculitis (AAV), ANCA-associated Vasculitis
- BefotertinibPhase 32 trials
Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy
- Bemnifosbuvir-RuzasvirBEM, RZRPhase 32 trials
Atea Pharmaceuticals, Inc. · HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection
- BFB759Phase 32 trials
Bluefin Biomedicine, Inc. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)
- BGM0504 AdministeredPhase 32 trials
BrightGene Bio-Medical Technology Co., Ltd. · Type 2 Diabetes Mellitus (T2DM)
- BHB-1893Phase 32 trials
Braveheart Bio, Inc. · Cardiomyopathy, Hypertrophic Non-Obstructive, Cardiomyopathy, Hypertrophic Obstructive
- BHV-1300Phase 32 trials
Biohaven Therapeutics Ltd. · Graves Disease, Graves' Disease
- BHV-2000Taldefgrobep, BMS-986089Phase 32 trials
Biohaven Pharmaceuticals, Inc. · Spinal Muscular Atrophy, Neuromuscular Diseases, SMA
- BI 1015550Phase 32 trials
Boehringer Ingelheim · Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis
- BionetideNA-921Phase 32 trials
Biomed Industries, Inc. · Rett Syndrome
- BisphosphonatePhase 32 trials
Ultragenyx Pharmaceutical Inc · Osteogenesis Imperfecta
- bivalent enterovirus vaccinePhase 32 trials
Sinovac Biotech Co., Ltd · Hand, Foot, and Mouth Disease(HFMD), Hand, Foot and Mouth Disease, Herpangina
- BL-8040Phase 32 trials
BioLineRx, Ltd. · Multiple Myeloma, Pancreatic Adenocarcinoma
- BL-M11D1Phase 32 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Acute Myeloid Leukemia, Myelodysplastic Syndromes
- BL-M14D1Phase 32 trials
SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma
- BleximenibJNJ-75276617Phase 32 trials
Johnson & Johnson (Janssen) · Acute Leukemia, Leukemia, Myeloid, Acute
- BR005-036CPhase 32 trials
Brise Pharmaceuticals Co., Ltd. · Migraine, With or Without Aura
- BrenetafuspIMC-F106CPhase 32 trials
Immunocore Ltd · Select Advanced Solid Tumors, Advanced Melanoma
- BuagafuranPhase 32 trials
Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder
- Buagafuran mimicPhase 32 trials
Beijing Union Pharmaceutical Factory Ltd · Generalized Anxiety Disorder
- BV100Phase 32 trials
BioVersys SAS · Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP), Colistin Resistanrt ABC
- C.difficile vaccinepreviously studiedPhase 32 trials
Pfizer · Clostridoides Difficile Associated Disease
- calcineurin inhibitorsPhase 32 trials
Sanofi · Dermatitis Atopic
- CanvuparatideMBX 2109Phase 32 trials
MBX Biosciences · Hypoparathyroidism
- CardiolRxPharmaceutically produced cannabidiolPhase 32 trials
Cardiol Therapeutics Inc. · Recurrent Pericarditis, Acute Myocarditis
- Carob FlourPhase 32 trials
Nemysis Ltd · Iron-deficiency
- CDK4Phase 32 trials
Qilu Pharmaceutical Co., Ltd. · Advanced ER+/HER2- Breast Cancer, Breast Cancer
- CenthaquinePMZ-2010Phase 32 trials
Pharmazz, Inc. · Acute Respiratory Distress Syndrome (ARDS), Hypovolemic Shock
- CF102NamodenosonPhase 32 trials
Can-Fite BioPharma · Pancreatic Adenocarcinoma, Pancreatic Cancer, Hepatocellular Carcinoma
- CHIKV VLP vaccinePhase 32 trials
Bavarian Nordic · Chikungunya Virus
- ClazakizumabLY5724886, CSL300Phase 32 trials
Eli Lilly · Atherosclerosis, Cardiovascular Disease, Obesity
- Clemizole HClEPX-100Phase 32 trials
Epygenix · Dravet Syndrome, Lennox Gastaut Syndrome
- ClifutinibHEC73543Phase 32 trials
Sunshine Lake Pharma Co., Ltd. · Leukemia, Acute Myeloid (AML), Acute Myeloid Leukemia, Adult
- CLR 131I-131-CLR1404, Iopofosine I 131 single dosePhase 32 trials
Cellectar Biosciences, Inc. · Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia
- CMP 001VidutolimodPhase 32 trials
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- CMS-D001Phase 32 trials
Dermavon Holdings Limited · Moderate to Severe Plaque Psoriasis, Moderate to Severe Atopic Dermatitis
- co-administration of aztreonamPhase 32 trials
Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia
- co-administration of cefepimePhase 32 trials
Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia
- CobolimabPhase 32 trials
GSK · Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma
- Combined metabolic activatorsPhase 32 trials
ScandiBio Therapeutics AB · Alzheimer Disease, Gout Disease
- Copper Cu 64 PSMA I&TPhase 32 trials
Curium US LLC · Prostate Cancer, Prostate Adenocarcinoma, Biochemical Recurrence of Malignant Neoplasm of Prostate
- CRB-701Phase 32 trials
Corbus Pharmaceuticals Inc. · Solid Tumor, Adult, Oropharyngeal Carcinoma (OPC)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.